This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview

This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

Comprehensive Review of Neurology Memorial Day Sale: 25% OFF

Comprehensive Review of Neurology

This activity carries a fee of $896.25 to review the content and receive credit.

Format

Board Review

Time to Complete

41.50 hours

Released

June 30, 2015

Expires

June 30, 2018

Maximum Credits

41.50 / AMA PRA Category 1 CreditsTM

Accredited Provider




This program is provided by Oakstone Publishing, LLC.

Producer

This program is produced by Oakstone Publishing, LLC.

Program Description

The Comprehensive Review of Neurology program consists of 45 audio lectures with accompanying study materials covering the full spectrum of modern clinical neurology. It is designed to improve the assessment and care of patients with neurological disorders and to keep neurologists on top of a rapidly evolving specialty area. The lectures are presented by an acclaimed group of teachers and practitioners, led by Course Director Martin A. Samuels, MD, an internationally recognized clinical neurologist at Brigham and Women's Hospital and Harvard Medical School.

Intended Audience

Neurologists in clinical practice, neurology residents and fellows, and psychiatrists preparing for the Neurology portion of the ABPN psychiatry exam

Educational Objectives

After taking part in this educational activity, participants should be better able to:

  • Perform a thorough history and neurological exam in order to recognize common and uncommon neurological diseases
  • Apply current neurological literature to the evaluation and management of patients with neurological disorders
  • Determine under which conditions imaging and labs tests would be necessary or unnecessary for diagnosis
  • Assess relevant treatment options and the need for referral to a subspecialist neurologist or specialist in another field
  • Predict and manage patient expectations regarding treatment options, outcomes, and prognosis

Topics and Speakers

Click here for a complete list of course topics and speakers.

Conflict Of Interest Disclosure Policy

It is the policy of Oakstone Publishing, LLC that the faculty and provider disclose real or apparent conflict of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Oakstone has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.

Faculty

Course Director
Martin A. Samuels, MD
Chairman, Department of Neurology
Brigham and Women’s Hospital
Miriam Sydney Joseph Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Speakers
Robert W. Baloh, MD
Professor of Neurology and Head and Neck Surgery
David Geffen School of Medicine at UCLA
Reed Neurological Research Center
Los Angeles, CA
Reports no commercial interest

Tracy T. Batchelor, MD, MPH
Giovanni Armenise Harvard Professor of Neurology
Harvard Medical School
Executive Director
Stephen E. and Catherine Pappas Center for Neuro-Oncology
Massachusetts General Hospital
Co-Leader, Brain Cancer Program
Dana-Farber/Harvard Cancer Center
Boston, MA
Research Grants: Pfizer (to institution, I serve as PI)
Advisory Role: Merck, Proximagen, Foundation Medicine, CancerPanels
Honoraria: UpToDate, Inc, Imedex

Ellen J. Bubrick, MD
Division of Epilepsy
Department of Neurology
Brigham and Women’s Hospital
Boston, MA
Reports no commercial interest

Rebecca C. Burch, MD
Assistant Neurologist, Department of Neurology
Brigham and Women’s Faulkner Hospital
Instructor in Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Gregory D. Cascino, MD
Whitney MacMillan, Jr. Professor of Neuroscience
Mayo Clinic College of Medicine
Enterprise Director of Epilepsy
Mayo Clinic
Rochester, MN
Reports no commercial interest

Thomas I. Cochrane, MD
Assistant Professor of Neurology
Harvard Medical School
Division of Neuromuscular Medicine
Brigham and Women’s Hospital
Boston, MA
Reports no commercial interest

Kirk R. Daffner, MD
Chief, Division of Cognitive and Behavioral Neurology
Department of Neurology
Brigham and Women’s Hospital
J. David and Virginia Wimberly Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Josep Dalmau, MD, PhD
Research Professor, ICREA-IDIBAPS Service of Neurology
Hospital Clinic
University of Barcelona
Adjunct Professor of Neurology
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA
Research Grants: Euroimmun, Lubeck German, unrestricted research grant Board_Membership: Editor in Chief Neurology: Neuroimmunology and Neuroinflammation
Expert Testimony: Yes for the U.S. Department of Justice
Honoraria: as invited speaker (e.g. grand rounds) Massachusetts General; Rush; Johns Hopkins
Patent Copyright License: Royalties from Athena Diagnostics for the use of Ma antibodies as a diagnostic test and from Euroimmun for the use of NMDAR antibodies as a diagnostic test. Licensing fee's from Mayo Clinic allowing them to use NMDAR as a diagnostic teset."

Rebecca D. Folkerth, MD
Director, Neuropathology Service
Brigham and Women’s Hospital
Director, Longwood Neuropathology Training Program
Consultant Neuropathologist
Boston Children’s Hospital
Consult in Medical Oncology
Dana-Farber Cancer Institute
Associate Professor of Pathology
Harvard Medical School
Boston, MA
Reports no commercial interest

Roy Freeman, MD
Professor of Neurology
Harvard Medical School
Director
Center for Autonomic and Peripheral Nerve Disorders
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA
Consultant/Advisory Boards: Lundbeck

Michael Ganetsky, MD
Assistant Professor of Emergency Medicine
Harvard Medical School
Core Medical Toxicology Faculty
Harvard Medical Toxicology Fellowship
MA/RI Poison Control Center
Director, Medical Toxicology Consult Service
Department of Emergency Medicine
Beth Israel Deaconess Medical Center
Boston, MA
Research-Grants: Boehringer Ingelheim
Honoraria: Elsevier, UpToDate, HMS Online CME

Michael D. Geschwind, MD, PhD
Professor of Neurology
Michael J. Homer Chair in Neurology
University of California, San Francisco
Memory and Aging Center
San Francisco, CA
Research Grants: NIH
Advisory Role: Best Doctors, Med-Legal Consulting for Lewis Brisbois, Bisgaard, and Smith
Board Membership: San Francisco Physicians for Social Responsibility
Employment: UCSF"

Mark Hallett, MD
President, International Federation of Clinical Neurophysiology
Chief, Human Motor Control Section
National Institute of Neurological Disorders and Stroke
National Institutes of Health
Bethesda, MD
Reports no commercial interest

Michael T. Hayes, MD
Vice Chair of Community Neurology
Brigham and Women’s Hospital
Boston, MA
Chief of Neurology Service
South Shore Hospital
South Weymouth, MA
Reports no commercial interest

Galen V. Henderson, MD
Director, Neuro-Critical Care
Brigham and Women’s Hospital
Assistant Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Lawrence J. Hirsch, MD
Professor of Neurology
Chief, Division of Epilepsy and EEG
Co-Director, Comprehensive Epilepsy Center
Yale University School of Medicine
New Haven, CT
Other: Sudden unexpected death in epilepsy
Research Grants: UCB-Pharma, Upsher-Smith, Lundbeck, Eisai and Sunovion (all sell anti-seizure medications)
Advisory Role: Lundbeck, Upsher-Smith, Neuropace, Glaxo-Smith-Kline, and Allergan
Honoraria: Natus; Neuropace (for speaking)"

Vikram Khurana, MD, PhD
Assistant in Neurology
Movement Disorders Unit
Massachusetts General Hospital
Boston, MA
Ownership_Interests: Scientific Co-Founder, Yumanity Therapeutics

Joshua P. Klein, MD, PhD
Chief, Division of Hospital Neurology
Brigham and Women’s Hospital
Associate Professor of Neurology
Assistant Professor of Radiology
Harvard Medical School
Boston, MA
Advisory Role: Guidepoint Global (Consultant)
Board Membership: American Society of Neuroimaging (Board of Directors)
Honoraria: American Academy of Neurology Institute, Audio-Digest Foundation (Lecturer, Course Director)"

Jong Woo Lee, MD
Assistant Professor of Neurology
The Edward B. Bromfield Epilepsy Program
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA
Research Grants: NINDS, UCB
Advisory Role: Advance Medical
Honoraria: American Clinical Neurophysiology Society
Independent Contractor: SleepMed/DigiTrace"

Robert G. Miller, MD
Medical Director at the Forbes Norris MDA
ALS Research Center
San Francisco, CA
Research Grants: Muscular Dystrophy Association, Synapse, Neuraltus
Advisory Role: Cytokinetics, Mitsubishi
Board Membership: ALS Association"

Edison K. Miyawaki, MD
Associate Neurologist
Brigham and Women’s Hospital
Assistant Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Mary Angela O’Neal, MD
Director of Women’s Neurology
Brigham and Women’s Hospital
Boston, MA
Reports no commercial interest

Robert M. Pascuzzi, MD
Program Director and Chair
Department of Neurology
Indiana University School of Medicine
Indianapolis, IN
Reports no commercial interest

Sashank Prasad, MD
Assistant Professor of Neurology
Harvard Medical School
Chief, Division of Neuro-Ophthalmology
Department of Neurology
Brigham and Women’s Hospital
Boston, MA
Reports no commercial interest

David C. Preston, MD
Professor of Neurology
Case Western Reserve University
Vice Chairman and Program Director
Neurological Institute
University Hospitals Case Medical Center
Cleveland, OH
Reports no commercial interest

Amy A. Pruitt, MD
Professor of Neurology
Vice Chair for Education
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, PA
Reports no commercial interest

Maisha T. Robinson, MD
Clinical Instructor
David Geffen School of Medicine at UCLA
Department of Neurology
Los Angeles, CA
Reports no commercial interest

Karen L. Roos, MD
John and Nancy Nelson Professor of Neurology
Indiana University School of Medicine
Indianapolis, IN
Reports no commercial interest

Allan H. Ropper, MD, FRCP, FACP
Raymond D. Adams Master Clinician and Executive Vice Chair
Department of Neurology
Brigham and Women’s Hospital
Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Thomas D. Sabin, MD
Professor and Vice Chair
Department of Neurology
Tufts University School of Medicine
Lecturer on Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Martin A. Samuels, MD
Chairman, Department of Neurology
Brigham and Women’s Hospital
Miriam Sydney Joseph Professor of Neurology
Harvard Medical School
Boston, MA
Reports no commercial interest

Michael H. Silber, MB, ChB
Professor of Neurology
Department of Neurology and Center for Sleep Medicine
Mayo Clinic College of Medicine
Rochester, MN
Employment: Mayo Clinic Rochester MN
Honoraria: UpToDate (Wolters Kluwer); American Academy of Neurology; American Academy of Sleep Medicine; Harvard University

Farzaneh A. Sorond, MD, PhD
Associate Professor of Neurology
Harvard Medical School
Associate Neurologist
Brigham and Women’s Hospital
Boston, MA
Reports no commercial interest

Reisa A. Sperling, MD
Professor of Neurology
Harvard Medical School
Director, Center for Alzheimer Research and Treatment
Brigham and Women’s Hospital
Director of Neuroimaging
Massachusetts Alzheimer’s Disease Research Center
Massachusetts General Hospital
Boston, MA
Research Grants: NIA, Eli Lilly, Janssen
Advisory Role: Roch, Isis, Genentech, Biogen, Janssen

James M. Stankiewicz, MD
Clinical Director
Partners MS Center
Assistant Professor of Neurology
Harvard Medical School
Brigham and Women’s Hospital
Boston, MA
Advisory Role: EMD serono, Biogen, Novartis, Genentech, Genzyme, Teva neuroscience

Lewis R. Sudarsky, MD
Head of the Movement Disorders Division
Department of Neurology
Brigham and Women’s Hospital
Harvard Medical School
Boston, MA
Reports no commercial interest

Brian J. Wainger, MD, PhD
Assistant Professor of Anesthesia, Critical Care and Pain Medicine
Assistant Professor of Neurology
Massachusetts General Hospital
Harvard Medical School
Boston, MA
Reports no commercial interest

Lawrence R. Wechsler, MD
Henry B. Higman Professor and Chair
Department of Neurology
University of Pittsburgh School of Medicine
Pittsburgh, PA
Advisory Role: Lundbeck & San Bio - consultant; DSMB - DIAS 3/4 & Biogen Idec; Steering Committee - ACT I Ownership Interests: Minor stockholder - Silk Road Medical

Eelco F.M. Wijdicks, MD
Professor of Neurology
Chair, Division of Critical Care Neurology
Mayo Clinic
Rochester, MN
Reports no commercial interest

Publishing Staff Disclosures

Oakstone Publishing, LLC has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, content reviewers, and editorial staff disclose no relevant commercial interests.

CME Course Advisor:
Sandy Mardant

CME Manager
sandy.mardant@ebix.com
205-437-3058

Credit

41.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Oakstone Publishing, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

Oakstone Publishing, LLC designates this enduring material for a maximum of 41.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Board of Psychiatry and Neurology has reviewed Comprehensive Review of Neurology and has approved this program as part of a comprehensive CME program, which is mandated by the ABMS as a necessary component of maintenance of certification.

Disclaimer

The opinions and recommendations expressed by the faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Oakstone Publishing, LLC name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

Instructions

METHOD OF PARTICIPATION: Once logged into the website, review the audio/videos, complete the comprehensive activity evaluation and score 70% or greater on the required post-test to assess the knowledge gained from reviewing the program. Once the activity and evaluation are complete and a satisfactory score is earned on the post test, you can print your CME certificate located under the certificate tab.

If you have any questions relating to the accreditation of this activity, please contact oakcmeoffice@ebix.com.

If you have any issues regarding the purchase process or getting to the course material, please contact myCME’s customer support at myCME.Support@haymarketmedical.com.

If you have any issues with the course material itself, including videos, post-tests, and credits, please contact Oakstone at oakwebmaster@ebix.com or 800-825-9806.

Refund Policy for Oakstone Products

Due to the nature of Oakstone’s product, its audio/video format and educational content, no refunds are permitted. You may return the product within 15 days of receipt and receive a credit reflective of the original price you paid for the item. This credit may be applied as payment to any product(s) produced by Oakstone Publishing, LLC. We guarantee your program against defects in materials. Simply return any defective materials, and we will replace them. To make a return, call 800-633-4743 for a Return Authorization Code. Complete the packing ticket and return with the program to 2700 Corporate Drive, Suite 100, Birmingham, AL 35242. We recommend shipping through UPS or FedEx. Return shipping fees are the responsibility of the purchaser.

System Requirements

TECHNICAL REQUIREMENTS
This site is best viewed using Internet Explorer 8 and higher, Current version of Chrome, Apple Safari 5.1.x and newer or Firefox 15.0 and newer. A broadband Internet connection is recommended. For all CME activities featuring video and/or audio you must have a sound card and speakers. To view graphic images and references that appear in separate "pop-up" windows, you must have JavaScript enabled on your computer.

COOKIE POLICY
Oakstone uses cookies and similar technologies like pixels and tags to ensure that we give you the best possible experience on our website. A cookie is a small file placed onto your device. Cookies enable us to identify your device, and enable the functioning of many features, including your ability to log into your account.
Older browsers may require the Adobe Flash Player. This browser plug-in is free, and available from the Adobe web site.

ONLINE STREAMING
Windows XP, Vista, 7 or 8 on Pc and Macintosh OS X or above on Mac computers with most current Flash player/Quicktime software and latest version of web browsers (Internet Explorer 7 or higher, Firefox 2.0 or higher, Safari 5 or higher and Chrome) for each.
Back to top
Secure payment system provided by